← All trials
NCT06044805
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 19, 2022
- Primary completion
- Mar 13, 2023
- Completion date
- Mar 15, 2023
- First posted
- Sep 21, 2023
- Last posted
- Sep 22, 2023
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wollega UniversityLead sponsor
- Ethiopian Public Health InstituteCollaborator
- Ethiopian Public Health InstituteStudy director
- Ethiopian Public Health InstituteOfficial
- Wollega UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.